Provectus Biopharmaceuticals Inc (PVCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Operating Expenses | 6,300 | 8,054 | 13,320 | 24,512 | 24,654 |
| Operating Income | -6,300 | -8,054 | -13,320 | -24,512 | -24,654 |
| Interest Expense | 1,455 | 970 | 402 | 0 | 0 |
| Other Income | 832 | 871 | 204 | 85 | 152 |
| Pre-tax Income | -6,923 | -8,153 | -13,518 | -24,427 | -24,502 |
| Net Income Continuous | -6,923 | -8,153 | -13,518 | -24,427 | -24,502 |
| Net Income | $-6,923 | $-8,153 | $-13,518 | $-24,427 | $-24,502 |
| EPS Basic Total Ops | -0.02 | -0.02 | -0.04 | -0.12 | -0.13 |
| EPS Basic Continuous Ops | -0.02 | -0.02 | -0.04 | -0.10 | -0.13 |
| EPS Diluted Total Ops | -0.02 | -0.02 | -0.04 | -0.12 | -0.13 |
| EPS Diluted Continuous Ops | -0.02 | -0.02 | -0.04 | -0.10 | -0.13 |
| EPS Diluted Before Non-Recurring Items | -0.02 | N/A | N/A | N/A | N/A |
| EBITDA(a) | $-5,615 | $-7,369 | $-12,633 | $-23,828 | $-23,970 |